- Home
- EVT vs BHVN Comparison
EVT vs BHVN Comparison
Compare EVT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVT
- BHVN
- Stock Information
- Founded
- EVT 2003
- BHVN 2013
- Country
- EVT United States
- BHVN United States
- Employees
- EVT N/A
- BHVN N/A
- Industry
- EVT Finance Companies
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- EVT Finance
- BHVN Health Care
- Exchange
- EVT Nasdaq
- BHVN Nasdaq
- Market Cap
- EVT 1.6B
- BHVN 1.9B
- IPO Year
- EVT N/A
- BHVN 2017
- Fundamental
- Price
- EVT $21.29
- BHVN $20.37
- Analyst Decision
- EVT
- BHVN Strong Buy
- Analyst Count
- EVT 0
- BHVN 14
- Target Price
- EVT N/A
- BHVN $63.15
- AVG Volume (30 Days)
- EVT 177.2K
- BHVN 1.7M
- Earning Date
- EVT 01-01-0001
- BHVN 05-08-2025
- Dividend Yield
- EVT 9.31%
- BHVN N/A
- EPS Growth
- EVT N/A
- BHVN N/A
- EPS
- EVT 6.63
- BHVN N/A
- Revenue
- EVT $69,404,302.00
- BHVN N/A
- Revenue This Year
- EVT N/A
- BHVN N/A
- Revenue Next Year
- EVT N/A
- BHVN $65.26
- P/E Ratio
- EVT $3.21
- BHVN N/A
- Revenue Growth
- EVT N/A
- BHVN N/A
- 52 Week Low
- EVT $19.20
- BHVN $15.79
- 52 Week High
- EVT $25.83
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- EVT 38.74
- BHVN 39.78
- Support Level
- EVT $20.04
- BHVN $15.79
- Resistance Level
- EVT $22.24
- BHVN $19.30
- Average True Range (ATR)
- EVT 0.90
- BHVN 2.20
- MACD
- EVT -0.04
- BHVN 0.26
- Stochastic Oscillator
- EVT 48.60
- BHVN 42.84
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.